Annual Report

Vir Biotechnology, Inc. Filed 2024-02-26 Acc 0001628280-24-006852

Documents 1

2025-02-27 10-K Annual Report
2024-02-26 144 Sale of Securities
2024-02-26 4 EVP & Chief Technology Officer sold 12,296 shares at $10.05 ($123,521)
2024-02-26 4 EVP & Chief Medical Officer sold 14,568 shares at $10.05 ($146,344)
2024-02-26 4 Director sold 27,750 shares at an average $11.07 ($307,259)
2024-02-26 10-K Annual Report
2023-02-28 10-K Annual Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading vir-20231231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…